cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-expressing macrophages drive age-related decline CD38 as theranostic target in
CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link The CD38 glycohydrolase and the NAD sink: implications for pathological conditions American Journal of Physiology Cell Physiology American Physiological Society Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3



